Navigation Links
Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update
Date:3/18/2013

ch 18, 2013 at 2:00 p.m. ET and will remain available until April 1, 2013.  The replay can be accessed at 1-877-870-5176 (Toll-Free/North America) or 1-858-384-5517 (International/Toll) using Conference ID: 4075429. An audio replay of the call will also be available on the Company's website, http://www.celsion.com, for 30 days after 2:00 p.m. ET Monday, March 18, 2013.

About ThermoDox® ThermoDox® is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers.  ThermoDox® is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis and a Phase II clinical trial for recurrent chest wall breast cancer.  Localized mild hyperthermia (39.5 - 42 degrees Celsius) created by radiofrequency ablation (RFA) releases the entrapped doxorubicin from the liposome.  This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor.  On January 31, 2013, Celsion announced that ThermoDox® in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma, also known as primary liver cancer.  Celsion is conducting additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox®.

About Celsion Corporation Celsion is dedicated to the development and commercialization of innovative cancer drugs, including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology.  Celsion has research, license or commercialization agreements with leading institutions, including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of '/>"/>

SOURCE Celsion Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
4. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
5. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
6. Luminex Corporation Reports First Quarter 2012 Results
7. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
8. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
9. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... Sept. 7, 2011 The Long Term Care Pharmacy ... Medicare D Residents in Skilled Nursing Facilities," has been ... Pharmacist, the official peer-reviewed journal of the American Society ... study to measure the quantity and the value of ...
... HEWA) a leading VIPPS accredited retail mail-order pharmacy, today ... will present at the Kaufman Brothers 14th Annual Investor ... Time on September 7, 2011. The public ... of the presentation on the Investor Relations section of ...
Cached Medicine Technology:LTCPA Study Quantifying Unused Medicare Part D Drugs in Skilled Nursing Facilities Published in The Consultant Pharmacist 2
(Date:8/30/2014)... MA (PRWEB) August 31, 2014 In a ... eat dog’ approach, Karma Web Group, LLC launches a game ... and Android the newly launched Ultimate Karma app is a ... with new levels of play, the game pulls double-duty by ... the same time. , Designed to reward gamers for consistently ...
(Date:8/30/2014)... August 31, 2014 This Labor Day, ... growing union in New York State and nationwide, is ... jobs and the best quality of care to New ... recent years, thousands of healthcare workers in the region ... families by becoming members of the healthcare workers’ union. ...
(Date:8/30/2014)... Atlanta based automotive group Jim Ellis Automotive ... and awareness for ALS by participating in the popular ... even Vice President Jimmy Ellis all participated in the ... viewed on their Youtube page; https://www.youtube.com/watch?v=pxufyxVo9j0 . , ... and staff also took the opportunity to challenge various ...
(Date:8/30/2014)... distinguished wedding dress supplier, has gained a great market response ... the company has unveiled its beautiful collection of “ flowy ... these brand new products are provided with big discounts, up ... unveil the new and trendy bridesmaid outfits and launch the ... low prices now. The purpose of our company is to ...
(Date:8/30/2014)... The Truth about Six Pack Abs is a ... users some shocking foods that can burn belly fat, unique ... as well as some motivation secrets for successful fitness. , ... one unique trick that can help users reduce junk-food cravings. ... people might think, cardio exercise routines are not the best ...
Breaking Medicine News(10 mins):Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 3Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 4Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2
... chronic myelogenous leukemia works for patients who have developed ... than other medications in its class, a research team ... D. Anderson Cancer Center reports at the 49th annual ... has shown good efficacy and very little toxicity compared ...
... Inc., a,developer of innovative technologies and products ... provider of QuantiGene(R) and,QuantiGene Plex(R) products for ... they have been awarded Frost & Sullivan,s ... of the Year,Award. Frost & Sullivan, a ...
... Dec. 11, 2007 Researchers at UT Southwestern Medical ... of Cushing syndrome, a metabolic disorder caused by adrenal ... The study, appearing in the December issue of the ... surgical outcomes reported in patients with subclinical Cushing syndrome ...
... 10 California,s,Fair Political Practices Commission today agreed ... cell board member John Reed, the,Foundation for Taxpayer ... non-profit consumer advocacy organization filed the,complaint two weeks ... the Burnham,Institute for Medical Research, because he improperly ...
... patients are suffering unnecessarily because they wrongly believe that morphine ... dying and as a last resort rather than seeing them ... life. , In a study published online today (Tuesday 11 ... in palliative care also say the belief that opioids hasten ...
... Dec. 10 Novo Nordisk Inc.,today announced the company ... Exubera(R) infringed patents owned by Novo Nordisk.,The patents cover ... originally filed in August 2006 in United States,Federal Court ... Nordisk is a healthcare company with an 84-year history ...
Cached Medicine News:Health News:Early Phase II results show bosutinib safe, effective for CML 2Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 2Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 3Health News:UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy 2Health News:UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy 3Health News:Fair Political Practices Commission Will Investigate Stem Cell Conflict of Interest 2Health News:Morphine: a comfort measure for the dying or pain control for the living? 2Health News:Morphine: a comfort measure for the dying or pain control for the living? 3Health News:Morphine: a comfort measure for the dying or pain control for the living? 4
For use with catalog #0540, 0887....
For use with catalog #0540....
For use with catalog #0454....
Determination of FDP in Plasma by Latex Agglutination, 60 tests.Microlatex particles coated with mouse monoclonal anti-human FDP antibodies....
Medicine Products: